CAN/534
WTO/TBT
CA Canada
  • 11 - Health care technology
2017-12-26
2017-11-08

Drug products containing controlled substances (ICS 11.120)

Notice to interested parties – Proposed regulations amending regulations under the Controlled Drugs and Substances Act with respect to the destruction of controlled substances and international travel with controlled substances prescribed for personal medical use. (3 page(s), in English; 3 page(s), in French)

This regulatory proposal aims to provide a long-term solution to address three problematic areas that are currently only addressed using temporary measures: the destruction of unserviceable stock containing certain controlled substances by pharmacists, practitioners and persons in charge of hospitals; the return of prescription drugs containing controlled substances by individuals to pharmacies for destruction; and individuals entering or leaving Canada with controlled substances for personal medical use. This notice provides interested stakeholders with the opportunity to provide comments on Health Canada's intent to amend the Narcotic Control Regulations (NCR), the Benzodiazepines and Other Targeted Substances Regulations (BOTSR) and Part G of the Food and Drug Regulations (FDR-G) to address these identified gaps and inconsistencies. The publication of this notice in the Canada Gazette, Part I, initiates a 60-day comment period.